Sue, S.; Sato, T.; Matsubayashi, M.; Kaneko, H.; Irie, K.; Maeda, S.
Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for Helicobacter pylori Eradication as Fourth-Line Regimen: An Interventional Study. Microorganisms 2024, 12, 2104.
https://doi.org/10.3390/microorganisms12102104
AMA Style
Sue S, Sato T, Matsubayashi M, Kaneko H, Irie K, Maeda S.
Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for Helicobacter pylori Eradication as Fourth-Line Regimen: An Interventional Study. Microorganisms. 2024; 12(10):2104.
https://doi.org/10.3390/microorganisms12102104
Chicago/Turabian Style
Sue, Soichiro, Takeshi Sato, Mao Matsubayashi, Hiroaki Kaneko, Kuniyasu Irie, and Shin Maeda.
2024. "Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for Helicobacter pylori Eradication as Fourth-Line Regimen: An Interventional Study" Microorganisms 12, no. 10: 2104.
https://doi.org/10.3390/microorganisms12102104
APA Style
Sue, S., Sato, T., Matsubayashi, M., Kaneko, H., Irie, K., & Maeda, S.
(2024). Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for Helicobacter pylori Eradication as Fourth-Line Regimen: An Interventional Study. Microorganisms, 12(10), 2104.
https://doi.org/10.3390/microorganisms12102104
